Insulin Pump Industry Forecast Analysis Report 2025 | Worldwide Insulin Pump Market Projected to Reach US$ 7.27 Billion by 2030 at a Compound Annual Growth Rate (CAGR) of 9.10% - as per ResearchAndMarkets.com findings

Insulin Pump Industry Forecast Analysis Report 2025 | Worldwide Insulin Pump Market Projected to Reach US$ 7.27 Billion by 2030 at a Compound Annual Growth Rate (CAGR) of 9.10% - as per ResearchAndMarkets.com findings

The global insulin pumps market is expected to grow significantly from 2021 to 2030, driven by the increasing prevalence of diabetes, especially type 1 diabetes, and technological advancements in insulin pump design. The market is projected to expand from a valuation of USD 4.31 billion in 2024 to USD 7.27 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.10% [1].

Drivers and Trends

The rising number of diabetes cases globally, predominantly type 1 diabetes, is one of the most significant factors fueling the market growth. The type 1 diabetes segment is expected to grow at the fastest CAGR of 9.31% [1]. Technological advancements, such as improved design, functionality, and integration with other diabetes management devices, are enhancing user convenience and outcomes, attracting more users and healthcare providers.

Insulin pumps, as a product category, held over 65% of the global market share in 2024, indicating strong adoption compared to other related devices [1]. Hospitals currently constitute the largest end-user segment, highlighting the importance of clinical settings and specialized care for insulin pump usage [1].

Geographical Insights

North America dominates the market with over 38% share, driven by advanced healthcare infrastructure and reimbursement policies. On the other hand, the Asia-Pacific (APAC) region demonstrates the highest growth rate during this period due to increasing healthcare access and diabetes prevalence [1].

Key Players and Innovations

The insulin pump landscape is a competitive space with established industry leaders, innovative startups, and strategic collaborations. Companies like Medtronic, Novo Nordisk, Insulet Corporation, Tandem Diabetes Care, and F. Hoffmann-La Roche are at the forefront of this market.

Medtronic, for instance, is enhancing its MiniMed series, including the 780G system, a hybrid closed-loop pump that automatically adjusts insulin delivery based on CGM readings. Insulet Corporation focuses on discreet, wearable insulin delivery with its Omnipod 5, featuring automated insulin dosing with real-time glucose data.

Partnerships with CGM companies like Dexcom and Abbott have become standard, allowing pumps to make real-time insulin adjustments based on glucose levels. Many vendors are focusing on building ecosystems that combine insulin pumps with mobile apps, AI algorithms, and CGM devices to create a seamless user experience.

Future Developments

Vendors are heavily investing in R&D to develop next-generation insulin pumps with features like touchscreen displays, Bluetooth connectivity, and closed-loop automation. Advances in diabetes technology have significantly enhanced the capabilities and appeal of insulin pumps, including integration with CGM systems, automated insulin delivery, Bluetooth-enabled smart pumps, AI and machine learning for predictive insulin dosing, user-friendly interfaces, discreet designs, and better battery life.

The report, which covers data on 23 vendors, also highlights the surge in product approvals, such as Medtronic MiniMed 780G in 2023 and Tandem Mobi in 2024. The forecasted market value by 2030 is $7.27 Billion.

[1] Global Insulin Pumps Market Size, Share & Industry Trends Analysis Report By Product (Insulin Pump, Insulin Cartridge, Insulin Pump Accessories), By End-use (Hospitals, Home Care Settings, Diabetes Clinics), By Region, And Segment Forecasts, 2021 - 2030 [2] Global Infusion Pumps Market Size, Share & Industry Trends Analysis Report By Product (Syringe Infusion Pumps, Insulin Infusion Pumps, Electronic Infusion Pumps), By Application (Oncology, Cardiology, Neurology), By End-use (Hospitals, Home Care Settings), And Geography Forecast, 2020 - 2026

1. The advancements in cloud technology are expected to revolutionize medical-conditions management, as insights from continuous glucose monitoring (CGM) devices can be seamlessly integrated into health-and-wellness apps for real-time patient monitoring.
2. Science and technology are collaborating to develop infrastructure for implementing smart city projects, which leverage insulin pumps as an example of IoT devices aimed at improving health and wellness for citizens.
3. The increasing prevalence of diabetes, particularly type 1 diabetes, has led to a growing need for news and updates regarding technological advancements in insulin pump design, placing technology at the center of ongoing dialogue in the news sector.

Read also: